COVID-19

COVID-19 updates and news to know as of May 16, 2022.

A session at the 40th Annual Meeting of the European Society for Pediatric Infectious Diseases looks at how the pandemic impacted the used of antimicrobials.

Investigators examined whether rapid antigen tests were less sensitive to variants of concern. Though the tests detected Omicron, all but 1 were less effective in detecting the Delta variant.

The administration also pledged to continue its work with existing pharmacy partners to improve the patient experience.

The country's COVID-19 death toll is nearing 1 million.

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children.

Respondents to a recent poll were still hesitant to get the Pfizer-BioNTech shot.

Data from COVID-19 vaccine distribution could spark improvements for future vaccination efforts.

A recent study evaluated 4 million Tweets published in 2021.

There are no easy solutions for people who gained insurance coverage through Medicaid.

The amended authorizations apply to the Pfizer-BioNTech and Moderna COVID-19 vaccines.

Attitudes change over time but people need convincing.

Moderna has released preliminary data from the company's phase 2/3 trial of the vaccine in children aged younger than 6 years.

The AMA objects to pharmacy-based clinics as an access point for COVID-19 treatments.

The facilities will be inspected between March 9 and June 9, 2022.

NACDS CEO responds to comments by AMA president.

President Biden’s recent State of the Union address included a pharmacy Test to Treat iniativie for COVID-19.

Rural areas lag well behind their urban counterparts when it comes to COVID-19 vaccinations

Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.

COVID-19 updates and news to know as of February 28, 2022.

A large cohort study offers important data on what factors are frequently tied to severe cases of COVID-19 in the pediatric population.

The days of blanket mitigation strategies to protect children from COVID-19 are becoming a thing of the past. One model sheds light onto determining when strategies can be relaxed.

Recent treatment may affect the antibody response, particularly among those with hematologic cancers.

COVID-19 updates and news to know as of February 21, 2022.

Does anxiety justify an exemption from vaccine mandates among health care workers?